Dear Friends and Colleagues,

It is my pleasure to invite you to attend the Drug Hypersensitivity Meeting 4, an EAACI supported meeting (DHM4), which will take place in Rome from April 22 to 25, 2010.

In preparing DHM4, we have taken into account the needs of researchers and clinicians who wish to keep abreast of the latest developments regarding hypersensitivity reactions to drugs. In effect, like the previous Drug Hypersensitivity Meetings (Bern in 2004, Liverpool in 2006, and Paris in 2008), the DHM4 will bring together international experts with the aim of fostering the exchanges of knowledge in drug hypersensitivity and improving the management of a constantly evolving problem. Numerous international experts from various fields regarding drug hypersensitivity – researchers, clinicians, and representatives of regulatory agencies and pharmaceutical companies, many of whom belonging to the European Network for Drug Allergy (ENDA), the EAACI interest group on drug hypersensitivity – will be present and will provide an updating on pathogenic mechanisms of drug hypersensitivity reactions, as well as on their diagnosis and prevention. 

Professor Antonino Romano
DHM4 President